Last Updated : March 15, 2023
Details
FilesGeneric Name:
eptinezumab
Project Status:
Complete
Therapeutic Area:
Migraine
Manufacturer:
Lundbeck Canada Inc.
Brand Name:
Vyepti
Project Line:
Reimbursement Review
Project Number:
SR0743-000
NOC Status at Filing:
Post NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the prevention of migraine in adults who have at least four migraine days per month and have experienced an inadequate response, intolerance, or contraindication to at least two oral prophylactic migraine medications.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the prevention of migraine in adults who have at least 4 migraine days per month.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
| Call for patient/clinician input open | May 11, 2022 |
|---|---|
| Call for patient/clinician input closed | July 04, 2022 |
| Clarification: - Patient input submission received from Migraine Canada & Migraine Quebec | |
| Submission received | June 08, 2022 |
| Submission accepted | |
| Review initiated | June 23, 2022 |
| Draft CADTH review report(s) provided to sponsor for comment | September 08, 2022 |
| Deadline for sponsors comments | September 19, 2022 |
| CADTH review report(s) and responses to comments provided to sponsor | October 14, 2022 |
| Expert committee meeting (initial) | October 26, 2022 |
| Draft recommendation issued to sponsor | November 08, 2022 |
| Draft recommendation posted for stakeholder feedback | November 17, 2022 |
| End of feedback period | December 01, 2022 |
| Final recommendation issued to sponsor and drug plans | December 15, 2022 |
| Final recommendation posted | January 10, 2023 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | January 06, 2023 |
| CADTH review report(s) posted | March 15, 2023 |
Files
Last Updated : March 15, 2023